Shares of Novavax (NVAX) gained 2.3% on Friday after the company announced that its experimental COVID-19 vaccine candidate, NVX-CoV2373, showed a strong immune …
Shares of Novavax (NVAX) fell almost 9% on Monday May 10 after the biotechnology company reported a loss in the first quarter. However, …
Reports of raw materials shortages causing production delays for Novavax’s (NVAX) COVID-19 vaccine forced the company to postpone signing a supply contract with …
Shares of Novavax popped almost 23% in Thursday’s extended market session after the biotech company announced that its coronavirus vaccine candidate showed to …
Novavax, a biotechnology company, and SK Group’s vaccine subsidiary extended their collaboration and license agreement for the manufacturing of an additional 40 million …
Shares of Novavax spiked almost 27% in Thursday’s extended market session after the biotech company announced that its coronavirus vaccine showed to be …
Novavax executives have seized the opportunity to bank profits and capitalize on the 3,000% rally in the stock’s share price as speculators continue …
Shares in Novavax are surging almost 8% in the pre-market session after the biotech company said additional data from the Phase 1/2 clinical …
Novavax reached an agreement in principle with the Government of Canada to supply up to 76 million doses of NVX-CoV2373, its COVID-19 vaccine candidate. Novavax …
Late-stage biotech Novavax (NVAX) has announced the beginning of a Phase 2b clinical trial in South Africa to evaluate the efficacy of NVX-CoV2373, Novavax’ COVID-19 …